Wendy & Emery Reves International Breast Cancer Symposium

The Wendy & Emery Reves International Breast Cancer Symposium is a premier event at UT Southwestern whose objectives are to review the recent progress in breast cancer research and improvements in the clinical care of patients with breast cancer. It provides information on the latest laboratory-based translational discoveries and new technologies, while exploring developments in treatment options, clinical trials, and population sciences.

Reves Symposium attendees include breast cancer providers and nursing professionals, basic and translational scientists, physician-scientists, clinical trialists, laboratory-based postdoctoral and clinical fellows, graduate students, patient advocates, and interested individuals from industry and North Texas communities.

CHAIR

Carlos L. Arteaga, M.D.

UT Southwestern SimmonsComprehensive Cancer Center

KEYNOTE SPEAKERS

Carlos Caldas, M.D.

University of Cambridge

Lisa Carey, M.D.

University of North Carolina at Chapel Hill

Tumor Heterogeneity

Nicholas Navin, Ph.D.

MD Anderson Cancer Center

Kornelia Polyak, M.D., Ph.D.

Dana-Farber Cancer Institute/Harvard

Charles Swanton, M.D., Ph.D.

The Francis Crick Institute

Cancer Risk and Health Disparities

Olufunimilayo (Funmi) Olopade, M.D., FACP

University of Chicago Cancer Center

Timothy R. Rebbeck, Ph.D.

Dana-Farber Cancer Institute/Harvard

Breast Cancer Detection/Imaging

Debra L. Monticciolo, M.D., FACR

Baylor Scott & White Medical Center

Robert M. Nishikawa, Ph.D., FAAPM, FSBI, FAIMBE, FSPIE

University of Pittsburgh

Cell Cycle and CDK4/6 Inhibitors

Andrew Koff, Ph.D.

Memorial Sloan Kettering Cancer Center

Hope S. Rugo, M.D.

University of California, San Francisco

Nicholas C. Turner, M.D., Ph.D.

Royal Marsden Hospital

De-escalation of Therapy

Armando Giuliano, M.D.

Cedars-Sinai Hospital

Joseph A. Sparano, M.D.

Montefiore Medical Center

Eric Winer, M.D.

Dana-Farber Cancer Institute/Harvard

Steroid Nuclear Receptors

Suzanne Conzen, M.D.

University of Chicago Medicine

Rinath Jeselsohn, M.D.

Dana-Farber Cancer Institute/Harvard

Lee Kraus, Ph.D.

UT Southwestern Simmons Comprehensive Cancer Center

Nikhil Wagle, M.D.

Dana-Farber Cancer Institute/Harvard